Search

Your search keyword '"Bergamasco, Bruno"' showing total 176 results
Start Over Author "Bergamasco, Bruno"
176 results on '"Bergamasco, Bruno"'

2. Subclinical electrophysiological alterations of phrenic nerve in chronic inflammatory demyelinating polyneuropathy

Author

Cocito, Dario, Ciaramitaro, Palma, Rota, Eugenia, Isoardo, Gianluca, Cannizzo, Silvana, Pogilo, Fabio, Tavella, Alessia, Castelli, Lorys, Paolasso, Ilaria, Bergamasco, Bruno, and Baldi, Sergio

Subjects
Demyelinating diseases -- Physiological aspects, Demyelinating diseases -- Development and progression, Demyelinating diseases -- Causes of, Demyelinating diseases -- Care and treatment, Neural conduction -- Measurement, Health
Published
2005

20. Exposure to Endocrine Disruptors and Nuclear Receptors Gene Expression in Infertile and Fertile Men from Italian Areas with Different Environmental Features

Author

La Rocca, Cinzia, primary, Tait, Sabrina, additional, Guerranti, Cristiana, additional, Busani, Luca, additional, Ciardo, Francesca, additional, Bergamasco, Bruno, additional, Perra, Guido, additional, Mancini, Francesca, additional, Marci, Roberto, additional, Bordi, Giulia, additional, Caserta, Donatella, additional, Focardi, Silvano, additional, Moscarini, Massimo, additional, and Mantovani, Alberto, additional

Published
2015
Full Text
View/download PDF

28. Exposure to Endocrine Disrupters and Nuclear Receptor Gene Expression in Infertile and Fertile Women from Different Italian Areas

Author

La Rocca, Cinzia, primary, Tait, Sabrina, additional, Guerranti, Cristiana, additional, Busani, Luca, additional, Ciardo, Francesca, additional, Bergamasco, Bruno, additional, Stecca, Laura, additional, Perra, Guido, additional, Mancini, Francesca, additional, Marci, Roberto, additional, Bordi, Giulia, additional, Caserta, Donatella, additional, Focardi, Silvano, additional, Moscarini, Massimo, additional, and Mantovani, Alberto, additional

Published
2014
Full Text
View/download PDF

29. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study

Author

Vigliani, Mc, Magistrello, M, Polo, P, Mutani, Roberto, Chio', Adriano, Calvo, Andrea, Di Vito, N, Vercellino, M, Bertolotto, A, Bottacchi, E, Cocito, D, Giordana, Maria Teresa, Leone, M, Mazzini, L, Mora, G, Terreni, Aa, Schiffer, Davide, Bergamasco, Bruno, Tribolo, A, Sciolla, R, Mondino, F, Gaviani, P, Monaco, Francesco, De Mattei, M, Morgando, E, Sosso, L, Gionco, M, Morino, U, Nobili, M, Appendino, L, Piazza, D, Oddenino, E, Liboni, W, Vaulag, Ferrari, G, Favero, M, Doriguzzi Bozzo, C, Santamaria, P, Massazza, U, Bollani, E, Villani, A, Conti, R, Balzarini, C, Palermo, M, Vergnano, F, Cordera, S, Buffa, C, Penza, Mt, Fassio, F, Meineri, P, Cognazzo, A, Mocellini, C, Dutto, A, Cucatto, A, Cavestro, C, Troniw, Corso, G, and Bottacchi, E.

Subjects
Adult, Aged, 80 and over, Male, Adolescent, Guillain-Barré syndrome, cancer, paraneoplastic polyneuropathy, Middle Aged, Guillain-Barre Syndrome, Risk Factors, Neoplasms, Confidence Intervals, Odds Ratio, Humans, Female, Poisson Distribution, Prospective Studies, Aged, Retrospective Studies
Abstract

The possible relationship between Guillain-Barré syndrome (GBS) and cancer is still controversial and the existence of a paraneoplastic GBS remains unconfirmed. To better define whether there is a relationship between GBS and malignancy, we compared the observed and the expected number of patients with tumours in a population-based cohort of subjects with GBS. Clinical differences between GBS patients with or without malignancies were analysed. Data were obtained from the Piemonte and Valle d'Aosta Register for GBS (PARGBS) (years 1990-1998). GBS was diagnosed according to NINCDS criteria. The number of expected cases of malignancy in the PARGBS population was calculated using the incidence rate of all types of cancer (ICD codes 140-208) in Piemonte [1985-1987], and in the most important town of this region, that is Turin (years 1993-1997). In the nine-year period, 435 incident patients with GBS were found. Nine of them developed cancer in the six months preceding or following GBS; in seven of them, the diagnosis of cancer and GBS was concomitant. The expected number of malignant tumours was 3.7 (using the incidence in Piemonte) and 3.8 (using the incidence in Turin); therefore, the odds ratios were 2.43 (95 % CI, 1.11-4.62) and 2.37 (95% CI, 1.09-4.50), respectively (p0.01). Although the cases with malignancies were clinically similar to the other cases of GBS observed through the Register, the mortality in GBS patients with cancer was higher and was the final cause of death in two patients affected by severe cancer. These results suggest a possible correlation between some cases of GBS and cancer. However, GBS in cancer patients does not meet all the criteria for paraneoplastic diseases.

Published
2003

30. LINEE GUIDA PER IL TRATTAMENTO DELLA MALATTIA DI PARKINSON 2002

Author

Bergamasco, Bruno, Abbruzzese, G, Albanese, A, Antonini, A, Barone, P, Bonifati, V, Bonuccelli, U, Bracco, F, Corsini, G, Lamberti, P, Lanotte, Michele Maria Rosario, Lopiano, Leonardo, Martignoni, E, Morgante, L, Ruggieri, S, Scerrati, M, and Zappia, M.

Published
2002

36. The influence of endocrine disruptors in a selected population of infertile women

Author

Caserta, Donatella, primary, Bordi, Giulia, additional, Ciardo, Francesca, additional, Marci, Roberto, additional, La Rocca, Cinzia, additional, Tait, Sabrina, additional, Bergamasco, Bruno, additional, Stecca, Laura, additional, Mantovani, Alberto, additional, Guerranti, Cristiana, additional, Fanello, Emiliano Leonida, additional, Perra, Guido, additional, Borghini, Francesca, additional, Focardi, Silvano Ettore, additional, and Moscarini, Massimo, additional

Published
2013
Full Text
View/download PDF

37. Correlation of Endocrine Disrupting Chemicals Serum Levels and White Blood Cells Gene Expression of Nuclear Receptors in a Population of Infertile Women

Author

Caserta, Donatella, primary, Ciardo, Francesca, additional, Bordi, Giulia, additional, Guerranti, Cristiana, additional, Fanello, Emiliano, additional, Perra, Guido, additional, Borghini, Francesca, additional, La Rocca, Cinzia, additional, Tait, Sabrina, additional, Bergamasco, Bruno, additional, Stecca, Laura, additional, Marci, Roberto, additional, Lo Monte, Giuseppe, additional, Soave, Ilaria, additional, Focardi, Silvano, additional, Mantovani, Alberto, additional, and Moscarini, Massimo, additional

Published
2013
Full Text
View/download PDF

38. Pain affects the quality of life of neuropathic patients

Author

Cocito, Dario, Paolasso, Ilaria, Pazzaglia, C, Tavella, Alessia, Poglio, Fabio, Ciaramitaro, Palma, Scarmozzino, Antonio, Cossa, Federico, Bergamasco, Bruno, Padua, Luca, Tavella , Alessia, Padua, Luca (ORCID:0000-0003-2570-9326), Cocito, Dario, Paolasso, Ilaria, Pazzaglia, C, Tavella, Alessia, Poglio, Fabio, Ciaramitaro, Palma, Scarmozzino, Antonio, Cossa, Federico, Bergamasco, Bruno, Padua, Luca, Tavella , Alessia, and Padua, Luca (ORCID:0000-0003-2570-9326)

Abstract

The aim of this study was to verify the extent to which the presence of pain affects the quality of life (QoL) of neuropathic patients. The patients were selected in our Department of Peripheral Nervous System Diseases. We enrolled 120 consecutive patients with chronic polyneuropathy who had not received continuous pain therapy during the two months preceding study entry, and administered them the Total Neuropathy Score (TNS), the official Italian version of the SF-36 and the Italian Pain Questionnaire (QUID). Our main finding was that the QoL is affected not only by the presence of neuropathy, but also by the presence and intensity of pain: the physical aspect of the QoL correlated only weakly with the TNS, but pain was closely related to a worsening in this parameter; moreover, the mental domains of the SF-36 were only correlated with pain. Pain per se worsens the QoL of neuropathic patients, regardless of disease severity.

Published
2006

39. Exposure and effective dose biomarkers for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in infertile subjects: Preliminary results of the PREVIENI project

Author

La Rocca, Cinzia, primary, Alessi, Eva, additional, Bergamasco, Bruno, additional, Caserta, Donatella, additional, Ciardo, Francesca, additional, Fanello, Emiliano, additional, Focardi, Silvano, additional, Guerranti, Cristiana, additional, Stecca, Laura, additional, Moscarini, Massimo, additional, Perra, Guido, additional, Tait, Sabrina, additional, Zaghi, Carlo, additional, and Mantovani, Alberto, additional

Published
2012
Full Text
View/download PDF

42. A study of 3H-PK 11,195 binding to 'peripheral-type' benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy

Author

Ferrero, P., Rocca, Paola, Gualerzi, A., Benna, Paolo, Enrichens, F., Mao, P., Olivero, Giorgio, Ravizza, L., and Bergamasco, Bruno

Subjects
Adult, Liver Cirrhosis, Male, Scopolamine Derivatives, Parasympatholytics, Middle Aged, N-Methylscopolamine, Isoquinolines, Receptors, GABA-A, Hepatic Encephalopathy, Humans, Female, Lymphocytes, Biomarkers, Aged
Abstract

In an attempt to assess the involvement of the "peripheral-type" benzodiazepine receptors (pBDZR) in hepatic encephalopathy (HE), we examined the binding of the isoquinoline carboxamide derivative 3H-PK 11,195 to lymphocyte membranes from a group of patients with liver cirrhosis with or without clinical signs of HE and normal controls. Lymphocyte 3H-PK 11,195 binding is saturable, with high affinity and presents the pharmacological specificity corresponding to pBDZR. A significant 40% decrease in the number of 3H-PK 11,195 binding sites, without a concomitant change in the apparent affinity, is observed in the group with HE as compared to the controls, but not in that with liver diseases without HE. The decrease in binding capacity correlates significantly with the clinical grading of HE, but not with age, sex, aetiology of cirrhosis or presence of surgical shunt. In contrast to the reduction of pBDZR, 3H-N-methylscopolamine binding to lymphocyte muscarinic receptors is not affected in HE. These findings are consistent with a role for pBDZR in HE and may stimulate studies of endogenous modulators and pharmacological agents for these receptors in the disease.

Published
1991

43. α-Synuclein protects SH-SY5Y cells from dopamine toxicity

Author

Colapinto, Monica, primary, Mila, Silvia, additional, Giraudo, Sabrina, additional, Stefanazzi, Paola, additional, Molteni, Monica, additional, Rossetti, Carlo, additional, Bergamasco, Bruno, additional, Lopiano, Leonardo, additional, and Fasano, Mauro, additional

Published
2006
Full Text
View/download PDF

48. Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's disease

Author

Priano, Lorenzo, primary, Albani, Gianni, additional, Brioschi, Andrea, additional, Calderoni, Sara, additional, Lopiano, Leonardo, additional, Rizzone, Mario, additional, Cavalli, Roberta, additional, Gasco, Maria Rosa, additional, Scaglione, Francesco, additional, Fraschini, Franco, additional, Bergamasco, Bruno, additional, and Mauro, Alessandro, additional

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results